Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Manmohan Singh

Psychiatry Des Moines, IA Medical Doctor

NPI 1205821337 CMS profile 54957

600 42Nd St, Des Moines, IA 50312

Open in the dashboard

General payments

$408,479

804 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Manmohan Singh of Des Moines, IA is reported in the CMS Open Payments database as having received $408,479 across 804 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $552 8
2024 General $11,961 14
2023 General $52,644 65
2022 General $105,231 171
2021 General $93,703 186
2020 General $75,717 176
2019 General $68,672 184

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Manmohan Singh
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Manmohan Singh were reported at $552. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Manmohan Singh Psychiatry median Middle half National median
2019 $68,672 $184 $59–$605 $163
2020 $75,717 $119 $36–$372 $114
2021 $93,703 $143 $43–$576 $132
2022 $105,231 $153 $50–$590 $149
2023 $52,644 $170 $56–$651 $160
2024 $11,961 $179 $57–$673 $164
2025 $552 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alkermes, Inc. $198,081 300 payments
  2. AbbVie, Inc. $92,903 168 payments
  3. Allergan Inc. $73,419 231 payments
  4. ITI, Inc. $39,684 53 payments
  5. Axsome Therapeutics, Inc. $2,932 5 payments
  6. Teva Pharmaceuticals USA, Inc. $326 24 payments
  7. Otsuka America Pharmaceutical, Inc. $254 10 payments
  8. E.R. Squibb & Sons, L.L.C. $244 2 payments
  9. Janssen Pharmaceuticals, Inc $204 3 payments
  10. US WorldMeds, LLC $119 1 payment
  11. Other $313 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $368,218 168 payments
  2. Travel and Lodging $14,908 117 payments
  3. Food and Beverage $13,055 507 payments
  4. Consulting Fee $10,475 3 payments
  5. Honoraria $1,688 1 payment
  6. Education $136 8 payments
Products named General payments · program years 2019–2025
  1. ARISTADA Cns $135,824 223 payments
  2. ARISTADA Cns $135,824 223 payments
  3. ARISTADA Cns $135,580 202 payments
  4. ARISTADA Cns $135,580 202 payments
  5. ARISTADA INITIO $124,148 206 payments
  6. VRAYLAR Neuroscience $96,376 172 payments
  7. LYBALVI Cns $74,052 114 payments
  8. VRAYLAR Neuroscience $69,743 225 payments
  9. LYBALVI Cns $62,377 97 payments
  10. LYBALVI Cns $62,132 76 payments
  11. Other $106,660 188 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

804 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Iowa

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record